Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | CDK1 | P06493 | 2/20 | 0.31 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.31 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.31 |
| ▸ | CDK2 | P24941 | 2/20 | 0.31 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL297459 | 0.86 | MAPK1 (0.33) | MAPK1MAOAMAOBCDK1CCNB1 | |
| SCHEMBL28460876 | 0.84 | MAOA (0.32) | MAPK1MAOAMAOBCDK1CCNB1 | |
| SCHEMBL137566 | 0.84 | MAPK1 (0.34) | MAPK1MAOAMAOBCDK1CCNB1 | |
| SCHEMBL3341005 | 0.83 | MAPK1 (0.32) | MAPK1MAOAMAOBKDM4EALDH1A1 | |
| SCHEMBL295809 | 0.81 | MAOA (0.33) | MAPK1MAOAMAOBCDK1CCNB1 | |
| SCHEMBL11042030 | 0.81 | MAPK1 (0.35) | MAPK1MAOAMAOBCDK1CCNB1 | |
| SCHEMBL9188733 | 0.80 | MAPK1 (0.34) | MAPK1MAOAMAOBCDK1CCNB1 | |
| SCHEMBL11041752 | 0.79 | MAPK1 (0.35) | MAPK1MAOAMAOB | |
| SCHEMBL20222460 | 0.78 | KDM4E (0.32) | KDM4EALDH1A1PKM | |
| SCHEMBL12212529 | 0.78 | KDM4E (0.34) | MAPK1MAOAMAOBKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12554198-B2 | Functional hydrogen silsesquioxane resins and the use thereof | PIBOND OY (FI) | 2026-02-17 | — | — | US | disclosed |
| CN-111607089-B | Functional polyhydrosilsesquioxane resin compositions, methods of producing the same, and uses thereof | 彼博股份有限公司 | 2023-10-10 | — | — | CN | disclosed |
| US-20220162391-A1 | Functional hydrogen silsesquioxane resins and the use thereof | PIBOND OY (FI) | 2022-05-26 | — | — | US | disclosed |
| CN-111607089-A | Functional polyhydrosilsesquioxane resin compositions, methods of producing the same, and uses thereof | 彼博股份有限公司 | 2020-09-01 | — | — | CN | disclosed |
| US-8968458-B2 | Composition for resist underlayer film and process for producing same | JSR CORPORATION (JP) | 2015-03-03 | — | — | US | disclosed |
| US-8808446-B2 | Composition for resist underlayer film and process for producing same | JSR CORPORATION (JP) | 2014-08-19 | — | — | US | disclosed |
| US-20100151384-A1 | COMPOSITION FOR RESIST UNDERLAYER FILM AND PROCESS FOR PRODUCING SAME | JSR CORPORATION (JP) | 2010-06-17 | — | — | US | disclosed |
| US-20090050020-A1 | COMPOSITION FOR RESIST UNDERLAYER FILM AND PROCESS FOR PRODUCING SAME | JSR CORPORATION (JP) | 2009-02-26 | — | — | US | disclosed |
| EP-1855159-A1 | COMPOSITION FOR UNDERLAYER FILM OF RESIST AND PROCESS FOR PRODUCING THE SAME | JSR Corporation (JP) | 2007-11-14 | — | — | EP | disclosed |
| US-4450264-A | CROSSLINKED COPOLYMER OF A TRIS/TRIMETHYLSILOXY/SILYL ALKYL OR CYCLOHEXYL ACRYLATE; OXYGEN PERMEABILITY | POLYMATIC INVESTMENT CORP., N.V. (NL) | 1984-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12554198-B2 | Functional hydrogen silsesquioxane resins and the use thereof | MACF1, RTF1, ERCC4 | MAPK1 2966/4885MAOA 4610/4885MAOB 4594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.